Skip to main content

Year: 2023

Dominion Lending Centres Inc. Announces Q3-2023 Earnings Release Date

VANCOUVER, British Columbia, Oct. 24, 2023 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSX:DLCG) (“DLCG” or the “Corporation”) is pleased to announce that it will release its financial results for the three and nine months ended September 30, 2023, on November 7, 2023, after the market close. About Dominion Lending Centres Inc. Dominion Lending Centres Inc. is Canada’s leading network of mortgage professionals. DLCG operates through Dominion Lending Centres Inc. and its three main subsidiaries, MCC Mortgage Centre Canada Inc., MA Mortgage Architects Inc. and Newton Connectivity Systems Inc., and has operations across Canada. DLCG extensive network includes ~7,900 agents and ~540 locations. Headquartered in British Columbia, DLC was founded in 2006 by Gary Mauris and Chris Kayat. DLCG can be found on Twitter, Facebook and...

Continue reading

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

STOUGHTON, Mass., Oct. 24, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report third quarter 2023 financial results after the market closes on Tuesday, November 7, 2023. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET. Conference Call Information To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q3 2023 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s...

Continue reading

84% of US Business Leaders Expect Increased Holiday Sales, Targeting Eager-to-Spend Young Shoppers on Platforms like TikTok

Nearly 1 in 3 (31%) business leaders surveyed have been or plan to work with freelancers this holiday season for everything from social media marketing to market research and SEO support.Fiverr releases data on how small and medium US retailers are preparing for the holiday seasonFiverr conducted a nationwide survey of 1,000 consumers and 500 small-to-medium business leaders in partnership with Censuswide.NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) — Fiverr International Ltd. (NYSE: FVRR), the company that is changing how the world works together, today released data on how small and medium U.S. retailers are gearing up to tackle an unpredictable holiday shopping season. Fiverr conducted a nationwide survey of 1,000 consumers and 500 small-to-medium business leaders (excluding sole traders) in partnership with Censuswide....

Continue reading

Taysha Gene Therapies Presents New Preclinical In-vitro Data on TSHA-102 in Rett Syndrome Supporting miRARE Regulation of MECP2 Expression at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress

In vitro data demonstrated the miRARE control element downregulates MECP2 transgene and protein expression in response to cellular levels of MeCP2 in cell culture models Data recapitulate in vivo findings in neonatal mice demonstrating TSHA-102 regulated MeCP2 expression in deficient CNS cells and avoided toxic overexpression in cells already expressing MeCP2 Available clinical data from the two adult patients dosed with TSHA-102 in the first cohort (low dose) to be reported in mid-November; dosing of first pediatric Rett syndrome patient expected in the first quarter of 2024 DALLAS, Oct. 24, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system...

Continue reading

Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control Technology

OREM, Utah, Oct. 24, 2023 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a leading innovator in temperature control solutions, is excited to announce the successful testing of its groundbreaking liquid nitrogen temperature control technology, offering a promising alternative to hydrofluorocarbon (HFC) refrigerants in building air conditioning systems. The Environmental Protection Agency’s increased restrictions on using HFCs – potent greenhouse gases found in standard refrigerators and air conditioning systems – have propelled the search for sustainable alternatives. In response, RSI, having recently secured a patent for using liquid nitrogen or liquid air in cooling systems, undertook intensive testing to validate its effectiveness as a substitute for HFCs. Results conclusively demonstrated the technology’s...

Continue reading

TransCode Therapeutics Announces Preliminary Clinical Results in First Patient in Phase 0 Clinical Study with Lead Therapeutic Candidate, TTX-MC138

Evidence of Drug Accumulation in Metastatic Lesions BOSTON, Oct. 24, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced preliminary results with its lead therapeutic candidate, TTX-MC138, in the first patient enrolled in its Phase 0 clinical trial aimed at demonstrating delivery of TTX-MC138 to metastatic cancer, including metastases beyond those found in the liver. These preliminary data showed that radioactivity consistent with accumulation of TTX-MC138 was detected by noninvasive imaging in the regions of the metastatic lesions previously identified by fluorodeoxyglucose (FDG)/positron emission tomography (PET) (FDG/PET). In addition, radiolabeled TTX-MC138 had pharmacokinetic behavior consistent with...

Continue reading

Worksport Increases R&D for Terravis Energy Subsidiary’s Heat Pump Project

West Seneca, New York, Oct. 24, 2023 (GLOBE NEWSWIRE) — Worksport Ltd. (Nasdaq: WKSP; WKSPW) (“Worksport” or the “Company”) is pleased to announce that its subsidiary, Terravis Energy, Inc. (“Terravis Energy”), has increased R&D for its Cold Climate Residential Heat Pump, which is also a cooling product, due to expected large-scale growth in the North American and global markets. An air source heat pump, such as the one Terravis Energy is creating, utilizes the phase change of a special fluid to transfer heat. When heating your home, the pump takes heat from the outdoor air and uses the phase change from liquid to gas to bring that heat indoors. When cooling, it employs the opposite phase change, from gas to liquid, to move heat from inside your home to the outside. “Most North American households depend on fossil fuel-powered...

Continue reading

Onconova Expands Leadership Team with Two Key Appointments

Dr. Victor Moyo named Chief Medical OfficerMeena Arora joins as Vice President Global Medical Affairs and R&D NEWTOWN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company expanded its leadership team with the naming of Dr. Victor Moyo as Chief Medical Officer (CMO), and the addition of Meena Arora as Vice President, Global Medical Affairs and Research and Development (R&D). “We are delighted to have Dr. Moyo and Ms. Arora as integral members of our team at Onconova as we prepare to enter the next phase of development for narazaciclib and rigosertib, our novel and proprietary cell pathway inhibitors for oncology,”...

Continue reading

Tri Pointe Homes Named to Three Great Place to Work® Lists

National Homebuilder Recognized for Inclusive and Thoughtful Corporate Culture, Accessible and Transparent Leadership, and an Environment of Well-BeingTri Pointe Homes Has Been Named to Three 2023 Fortune Great Place to Work® ListsBased solely on employee feedback, the designations include 2023 Best Workplaces for Women, 2023 Best Workplaces for Millennials, and 2023 Best Workplaces in Construction.INCLINE VILLAGE, Nev., Oct. 24, 2023 (GLOBE NEWSWIRE) — Tri Pointe Homes® (NYSE: TPH), one of the largest homebuilders in the U.S., today announced its inclusion by Great Place to Work® and Fortune magazine on three Best WorkplacesTM lists, including 2023 Best Workplaces for Women™, 2023 Best Workplaces for MillennialsTM, and 2023 Best Workplaces in Construction™, adding to its growing list of employer excellence...

Continue reading

NewLake Capital CEO to Participate in the Zuanic and Associates “Lending in the Cannabis Sector” Virtual Panel on October 26th

NEW CANAAN, Conn., Oct. 24, 2023 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that Anthony Coniglio, CEO, will participate in the Zuanic and Associates “Lending in the Cannabis Sector” virtual panel. Mr. Coniglio will participate in a panel discussion hosted by Pablo Zuanic, Senior Equity Analyst and Managing Partner at Zuanic and Associates on Thursday, October 26, 2023 at 11:00 AM ET. For those interested in listening to the panel discussion please register here. About NewLake Capital Partners, Inc.NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.